EU Pharmaceutical Law Forum 2026

This leading European forum offers an in-depth legal exploration of current legislation and regulations within the pharmaceutical industry. The event brings together legal experts, policymakers, and market authorities to discuss merger control, patent law, market access, and the latest European regulatory frameworks that are currently profoundly transforming the sector.

Legal frameworks in a changing pharmaceutical sector

The European pharmaceutical market is currently undergoing profound changes due to legislative updates and increasing global competition. This forum provides a platform where industry professionals come together to unravel the complexity of these new regulations. Central to this is the question of how organizations can adapt to the latest guidelines from the European Commission and the European Medicines Agency (EMA).

Strategic insights and current case studies

During the meeting, leading experts share their knowledge on crucial legal themes. Participants receive practical tools regarding topics such as competition law, misleading communication about competitors, and the impact of mergers within the sector. In addition, extensive attention is paid to the procedures surrounding unannounced inspections by regulators and the legal obligations regarding the supply of medicines. Interactive panel discussions provide an opportunity to analyze concrete practical situations.

For whom is this forum indispensable?

This event is specifically designed for in-house counsel working within the biopharmaceutical industry and the broader life sciences. In addition, the meeting is highly relevant for private practice lawyers, policymakers at government institutions, and representatives of competition authorities. The program offers excellent opportunities to network with peers and engage directly with influential legislators.

Tags